Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Janux Therapeutics, Inc. Common Stock | JANX

AI Analysis of Janux Therapeutics, Inc. Common Stock

Janux Therapeutics is up a bit on the day, funds flowing in kept the price up 1.97% since yesterday.

It looks like Janux Therapeutics isn't currently at a very decisive point in regards to support/resistance levels. Janux Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. JANX might find some support at the 13.74 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-